115 related articles for article (PubMed ID: 26036499)
41. Reduction of immunosuppression for post-transplant lymphoproliferative disorder (PTLD): a single-center experience of allograft survival outcomes.
Pan K; Franke AJ; Skelton WP; Bishnoi R; Shah C; Dang NH; Alquadan K
Leuk Lymphoma; 2021 May; 62(5):1123-1128. PubMed ID: 33327817
[TBL] [Abstract][Full Text] [Related]
42. Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival.
Serre JE; Michonneau D; Bachy E; Noël LH; Dubois V; Suberbielle C; Kreis H; Legendre C; Mamzer-Bruneel MF; Morelon E; Thaunat O
Kidney Int; 2014 Jan; 85(1):182-90. PubMed ID: 23802193
[TBL] [Abstract][Full Text] [Related]
43. Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders.
Sarkozy C; Kaltenbach S; Faurie P; Canioni D; Berger F; Traverse-Glehen A; Ghesquieres H; Salles G; Bachy E; Alyanakian MA; Hermine O; Neven B; Macintyre E; Romana S; Molina TJ; Suarez F; Asnafi V; Bruneau J
Genes Chromosomes Cancer; 2017 Mar; 56(3):221-230. PubMed ID: 27750397
[TBL] [Abstract][Full Text] [Related]
44. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
[TBL] [Abstract][Full Text] [Related]
45. Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.
Mamzer-Bruneel MF; Lomé C; Morelon E; Levy V; Bourquelot P; Jacobs F; Gessain A; Mac Intyre E; Brousse N; Kreis H; Hermine O
J Clin Oncol; 2000 Nov; 18(21):3622-32. PubMed ID: 11054435
[TBL] [Abstract][Full Text] [Related]
46. Posttransplant lymphoproliferative disease: a series of 23 cases.
Martín-Gómez MA; Peña M; Cabello M; Burgos D; Gutierrez C; Sola E; Acedo C; Bailén A; Gonzalez-Molina M
Transplant Proc; 2006 Oct; 38(8):2448-50. PubMed ID: 17097963
[TBL] [Abstract][Full Text] [Related]
47. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
Khedmat H; Taheri S
Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272
[TBL] [Abstract][Full Text] [Related]
48. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
Raj R; Frost AE
J Heart Lung Transplant; 2005 Jun; 24(6):671-9. PubMed ID: 15949726
[TBL] [Abstract][Full Text] [Related]
49. Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation.
Taylor AL; Bowles KM; Callaghan CJ; Wimperis JZ; Grant JW; Marcus RE; Bradley JA
Transplantation; 2006 Aug; 82(3):375-81. PubMed ID: 16906036
[TBL] [Abstract][Full Text] [Related]
50. A Solid Mass in the Chest Wall.
Alagoz S; Yalin SF; Gulcicek S; Ozgur N; Altiparmak MR; Seyahi N
Prog Transplant; 2016 Dec; 26(4):386-388. PubMed ID: 27555070
[TBL] [Abstract][Full Text] [Related]
51. Current induction immunosuppression and post-heart transplant lymphoproliferative disorders.
Peraira JR; Segovia J; Fuertes B; Fernández JA; Escudier JM; Salas C; Pulpón LA
Transplant Proc; 2003 Aug; 35(5):2009-10. PubMed ID: 12962879
[TBL] [Abstract][Full Text] [Related]
52. A single-centre experience of post-renal transplant lymphoproliferative disorder.
Herzig KA; Juffs HG; Norris D; Brown AM; Gill D; Hawley CM; Cobcroft R; Petrie JB; Marlton P; Thomson D; Campbell SB; Nicol DL; Johnson DW
Transpl Int; 2003 Jul; 16(7):529-36. PubMed ID: 12734646
[TBL] [Abstract][Full Text] [Related]
53. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].
Deng Z; Jiang L; Zhou T; Shen C; Chen Q; Xia Q
Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):579-82. PubMed ID: 25224233
[TBL] [Abstract][Full Text] [Related]
54. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
[TBL] [Abstract][Full Text] [Related]
55. Post-transplant lymphoproliferative disease in liver transplant recipients.
Rubio-Manzanares Dorado M; Álamo Martínez JM; Bernal Bellido C; Marín Gómez LM; Suárez Artacho G; Cepeda Franco C; Wang J; Gómez Bravo MÁ; Padillo FJ
Rev Esp Enferm Dig; 2017 Jun; 109(6):406-413. PubMed ID: 28508661
[TBL] [Abstract][Full Text] [Related]
56. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients.
Libertiny G; Watson CJ; Gray DW; Welsh KI; Morris PJ
Br J Surg; 2001 Oct; 88(10):1330-4. PubMed ID: 11578286
[TBL] [Abstract][Full Text] [Related]
57. Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience.
Einollahi B; Lessan-Pezeshki M; Nourbala MH; Simforoosh N; Pourfarziani V; Nemati E; Nafar M; Basiri A; Pour-Reza-Gholi F; Firoozan A; Ghadiani MH; Makhdoomi K; Ghafari A; Ahmadpour P; Oliaei F; Ardalan MR; Makhlough A; Samimagham HR; Azmandian J; Razeghi E; Shahbazian H
Iran J Kidney Dis; 2008 Oct; 2(4):227-33. PubMed ID: 19377242
[TBL] [Abstract][Full Text] [Related]
58. [Clinicopathologic study of post-transplant lymphoproliferative disorders].
Zhang YN; Zhou XG; Wang CZ; Wei P; Zhang SH; Zheng YY
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):209-12. PubMed ID: 16776977
[TBL] [Abstract][Full Text] [Related]
59. Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study.
Lo RC; Chan SC; Chan KL; Chiang AK; Lo CM; Ng IO
J Clin Pathol; 2013 May; 66(5):392-8. PubMed ID: 23423516
[TBL] [Abstract][Full Text] [Related]
60. Post-Transplant Lymphoproliferative Disorder in Kidney Transplant Recipients: A Single-Center Experience in Japan.
Ishihara H; Shimizu T; Unagami K; Hirai T; Toki D; Omoto K; Okumi M; Imai Y; Ishida H; Tanabe K
Ther Apher Dial; 2016 Apr; 20(2):165-73. PubMed ID: 26948427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]